NO20091016L - Pyridooksazepin-progesteron reseptormodulatorer - Google Patents

Pyridooksazepin-progesteron reseptormodulatorer

Info

Publication number
NO20091016L
NO20091016L NO20091016A NO20091016A NO20091016L NO 20091016 L NO20091016 L NO 20091016L NO 20091016 A NO20091016 A NO 20091016A NO 20091016 A NO20091016 A NO 20091016A NO 20091016 L NO20091016 L NO 20091016L
Authority
NO
Norway
Prior art keywords
receptor modulators
progesterone receptor
pyridooksazepine
fluorodibenzo
oxazepine
Prior art date
Application number
NO20091016A
Other languages
English (en)
Inventor
Johannes Bernardus Maria Rewinkel
Birgitte Johanna Bernit Folmer
Maria Lourdes Ollero-Ollero
Hemen Ibrahim
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of NO20091016L publication Critical patent/NO20091016L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer nye progesteronreseptormodulatorer som er (cis)-8-fluordibenzo[b,f]pyrido[1,2-d]oksazepin-1-aminforbindelser og deres anvendelse.
NO20091016A 2006-09-27 2009-03-06 Pyridooksazepin-progesteron reseptormodulatorer NO20091016L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06121372 2006-09-27
PCT/EP2007/060225 WO2008037746A1 (en) 2006-09-27 2007-09-26 Pyridooxazepine progesteron receptor modulators

Publications (1)

Publication Number Publication Date
NO20091016L true NO20091016L (no) 2009-03-30

Family

ID=37813577

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091016A NO20091016L (no) 2006-09-27 2009-03-06 Pyridooksazepin-progesteron reseptormodulatorer

Country Status (28)

Country Link
EP (1) EP2066677B1 (no)
JP (1) JP2010504943A (no)
KR (1) KR20090064454A (no)
CN (1) CN101522689B (no)
AR (1) AR063018A1 (no)
AT (1) ATE478078T1 (no)
AU (1) AU2007302007B2 (no)
BR (1) BRPI0716830A2 (no)
CA (1) CA2664120A1 (no)
CL (1) CL2007002788A1 (no)
CO (1) CO6160325A2 (no)
CY (1) CY1110846T1 (no)
DE (1) DE602007008589D1 (no)
DK (1) DK2066677T3 (no)
ES (1) ES2349325T3 (no)
HK (1) HK1126767A1 (no)
HR (1) HRP20100526T1 (no)
IL (1) IL197365A0 (no)
MX (1) MX2009002804A (no)
NO (1) NO20091016L (no)
NZ (1) NZ575276A (no)
PE (1) PE20071451A1 (no)
PL (1) PL2066677T3 (no)
PT (1) PT2066677E (no)
RU (1) RU2009115643A (no)
SI (1) SI2066677T1 (no)
TW (1) TW200820975A (no)
WO (1) WO2008037746A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
CN101200429B (zh) * 2006-12-13 2012-08-22 上海睿智化学研究有限公司 2-硝基-4,5-二卤代苯酚类和2-氨基-4,5-二卤代苯酚类及其盐及其合成方法
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8852901A (en) * 2000-09-07 2002-03-22 Bayer Corporation Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
TWI297685B (en) * 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators

Also Published As

Publication number Publication date
CA2664120A1 (en) 2008-04-03
MX2009002804A (es) 2009-03-31
KR20090064454A (ko) 2009-06-18
CO6160325A2 (es) 2010-05-20
AU2007302007A1 (en) 2008-04-03
CN101522689B (zh) 2012-01-11
AR063018A1 (es) 2008-12-23
DK2066677T3 (da) 2010-11-08
PL2066677T3 (pl) 2011-02-28
JP2010504943A (ja) 2010-02-18
RU2009115643A (ru) 2010-11-10
CL2007002788A1 (es) 2008-04-18
NZ575276A (en) 2011-07-29
EP2066677B1 (en) 2010-08-18
IL197365A0 (en) 2009-12-24
SI2066677T1 (sl) 2010-12-31
CY1110846T1 (el) 2015-06-10
ATE478078T1 (de) 2010-09-15
PT2066677E (pt) 2010-11-10
WO2008037746A1 (en) 2008-04-03
DE602007008589D1 (de) 2010-09-30
BRPI0716830A2 (pt) 2013-11-05
EP2066677A1 (en) 2009-06-10
AU2007302007B2 (en) 2012-02-02
TW200820975A (en) 2008-05-16
ES2349325T3 (es) 2010-12-30
HK1126767A1 (en) 2009-09-11
HRP20100526T1 (hr) 2010-11-30
PE20071451A1 (es) 2008-10-30
CN101522689A (zh) 2009-09-02

Similar Documents

Publication Publication Date Title
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
DK1778236T3 (da) Modificerede pyrimidin-glucocorticoid-receptor-modulatorer
NO20092611L (no) Krystallinsk faststoff Rasagilin base
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
DK1833799T3 (da) 3-phenyl-pyrazol derivater, som modulatorer af 5-HT-2a-serotonin receptor nyttig til behandlingen af sygdomme relateret hertil
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
NO20093146L (no) Amino-pyridinderivater som S1P1/EDG1-reseptoragonister
WO2009012275A9 (en) Pyridone gpr119 g protein-coupled receptor agonists
MX2010004374A (es) Armazones proteinicos.
DK1928845T3 (da) Aminodiazepiner som toll-lignende receptor-modulatorer
NO20091395L (no) Nye tiofenderivater
DE602005018190D1 (de) Als modulatoren des dopamin-d3-rezeptors geeignete azabicycloä3.1.0ühexanderivate
DK1984345T3 (da) Benzoxaziner og beslægtede nitrogenholdige heterobicykliske forbindelser, der kan anvendes som mineralcorticoidreceptormodulerende midler
EA200800713A1 (ru) Аморфные твёрдые дисперсии
MX2010002028A (es) Metodos y composiciones para modular celulas t.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
UA104438C2 (uk) Спосіб одержання дабігатрану і його проміжних сполук
NO20070379L (no) Kjemiske forbindelser
EA201000258A1 (ru) Новые гербициды
DK2238110T3 (da) 5.6-bisaryl-2-pyridin-carboxamid-derivater, fremstilling heraf og terapeutisk anvendelse heraf som urotensin II-receptorantagonister
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
MX2009007336A (es) Indazoles substituidos con 5-furopiridinona.
DK2094684T3 (da) 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-on som CB1-receptor modulatorer
NO344044B1 (no) Nye triazindionderivater som GABA-B-reseptormodulatorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application